EQL Pharma AB (publ)

NGM:EQL 주식 보고서

시가총액: SEK 1.6b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

EQL Pharma 대차 대조표 상태

재무 상태 기준 확인 3/6

EQL Pharma 의 총 주주 지분은 SEK177.7M 이고 총 부채는 SEK120.1M, 이는 부채 대 자기자본 비율을 67.6% 로 가져옵니다. 총자산과 총부채는 각각 SEK373.8M 및 SEK196.0M 입니다. EQL Pharma 의 EBIT는 SEK32.6M 이며 이자보상배율은 5.7 입니다. SEK20.5M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

67.6%

부채 비율

SEK 120.09m

부채

이자 보상 비율5.7x
현금SEK 20.47m
주식SEK 177.73m
총 부채SEK 196.03m
총 자산SEK 373.76m

최근 재무 상태 업데이트

Recent updates

EQL Pharma AB (publ)'s (NGM:EQL) P/E Is Still On The Mark Following 30% Share Price Bounce

Jun 13
EQL Pharma AB (publ)'s (NGM:EQL) P/E Is Still On The Mark Following 30% Share Price Bounce

EQL Pharma (NGM:EQL) Is Doing The Right Things To Multiply Its Share Price

May 14
EQL Pharma (NGM:EQL) Is Doing The Right Things To Multiply Its Share Price

EQL Pharma's (NGM:EQL) Weak Earnings May Only Reveal A Part Of The Whole Picture

Feb 21
EQL Pharma's (NGM:EQL) Weak Earnings May Only Reveal A Part Of The Whole Picture

The Trend Of High Returns At EQL Pharma (NGM:EQL) Has Us Very Interested

Jun 28
The Trend Of High Returns At EQL Pharma (NGM:EQL) Has Us Very Interested

With EPS Growth And More, EQL Pharma (NGM:EQL) Makes An Interesting Case

Apr 28
With EPS Growth And More, EQL Pharma (NGM:EQL) Makes An Interesting Case

EQL Pharma AB (publ)'s (NGM:EQL) 26% Jump Shows Its Popularity With Investors

Feb 24
EQL Pharma AB (publ)'s (NGM:EQL) 26% Jump Shows Its Popularity With Investors

EQL Pharma (NGM:EQL) Is Achieving High Returns On Its Capital

Dec 19
EQL Pharma (NGM:EQL) Is Achieving High Returns On Its Capital

Does EQL Pharma (NGM:EQL) Deserve A Spot On Your Watchlist?

Jun 29
Does EQL Pharma (NGM:EQL) Deserve A Spot On Your Watchlist?

Is EQL Pharma (NGM:EQL) Using Too Much Debt?

Apr 29
Is EQL Pharma (NGM:EQL) Using Too Much Debt?

We Think EQL Pharma AB (publ)'s (NGM:EQL) CEO Compensation Looks Fair

Aug 10
We Think EQL Pharma AB (publ)'s (NGM:EQL) CEO Compensation Looks Fair

EQL Pharma (NGM:EQL) Hasn't Managed To Accelerate Its Returns

Jun 07
EQL Pharma (NGM:EQL) Hasn't Managed To Accelerate Its Returns

If You Like EPS Growth Then Check Out EQL Pharma (NGM:EQL) Before It's Too Late

Apr 16
If You Like EPS Growth Then Check Out EQL Pharma (NGM:EQL) Before It's Too Late

How Many EQL Pharma AB (publ) (NGM:EQL) Shares Have Insiders Sold, In The Last Year?

Mar 11
How Many EQL Pharma AB (publ) (NGM:EQL) Shares Have Insiders Sold, In The Last Year?

Are EQL Pharma's (NGM:EQL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 21
Are EQL Pharma's (NGM:EQL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Is EQL Pharma AB (publ)'s (NGM:EQL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 03
Is EQL Pharma AB (publ)'s (NGM:EQL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

What We Learned About EQL Pharma's (NGM:EQL) CEO Compensation

Jan 16
What We Learned About EQL Pharma's (NGM:EQL) CEO Compensation

Will the Promising Trends At EQL Pharma (NGM:EQL) Continue?

Dec 28
Will the Promising Trends At EQL Pharma (NGM:EQL) Continue?

What Type Of Shareholders Make Up EQL Pharma AB (publ)'s (NGM:EQL) Share Registry?

Dec 11
What Type Of Shareholders Make Up EQL Pharma AB (publ)'s (NGM:EQL) Share Registry?

EQL Pharma (NGM:EQL) Has Rewarded Shareholders With An Exceptional 436% Total Return On Their Investment

Nov 22
EQL Pharma (NGM:EQL) Has Rewarded Shareholders With An Exceptional 436% Total Return On Their Investment

재무 상태 분석

단기부채: EQL 의 단기 자산 ( SEK197.8M )이 단기 부채( SEK161.8M ).

장기 부채: EQL 의 단기 자산( SEK197.8M )이 장기 부채( SEK34.2M ).


부채 대 자본 내역 및 분석

부채 수준: EQL 의 순부채 대 자기자본 비율( 56.1% )은 높음으로 간주됩니다.

부채 감소: EQL 의 부채 대 자기자본 비율은 지난 5년간 14% 에서 67.6% 로 증가했습니다.

부채 범위: EQL 의 영업현금흐름이 마이너스이므로 부채가 제대로 상환되지 않습니다.

이자 보장: EQL 의 부채에 대한 이자 지급EBIT( 5.7 x 적용 범위)로 잘 충당됩니다.


대차 대조표


건강한 기업 발견하기